Charles River Laboratories | CRL - بدهکاران تجاری

قیمت سهام
170.05
تغییر روزانه
2.31 1.38%
ماهیانه
6.82%
سالیانه
46.90%
Q2 پیش بینی
179.83




بدهکاران تجاری تغییر دادن تاریخ
Agilent USD 1.52B 34M 2025-12
Align Technology USD 1.1B 2.38M 2025-12
Bio-Rad Laboratories USD 464.7M 5.2M 2025-09
Bruker USD 544.9M 6M 2025-12
Cardinal Health USD 13.66B 108M 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Cigna USD 31.71B 3.74B 2025-09
Concord Medical Services Hldg CNY 57.36M 40.75M 2025-06
CVS Health USD 39.78B 4.08B 2025-12
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 688M 34M 2025-12
Elevance Health USD 22.79B 1.25B 2026-03
Galapagos EUR 199.75M 122.08M 2025-12
Humana USD 3.27B 586M 2025-12
Illumina USD 854M 125M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
IQVIA Holdings USD 3.43B 113M 2025-12
Laboratory Of America USD 2.26B 4.5M 2025-12
Lonza CHF 1.78B 55M 2025-12
McKesson USD 28.21B 73M 2025-12
Merck EUR 4.44B 293M 2025-12
Mettler Toledo International USD 778.24M 90.98M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Quest Diagnostics USD 1.59B 179M 2026-03
Revvity USD 744.67M 64.41M 2025-12
Thermo Fisher Scientific USD 9.2B 304M 2026-03
United Therapeutics USD 350.2M 52.5M 2025-12
UnitedHealth USD 26.59B 3.57B 2026-03
Veradigm USD 175.72M 58.76M 2022-12
Waters USD 828.84M 80.32M 2025-12
West Pharmaceutical Services USD 685.6M 111.2M 2026-03